Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Taiwan / NCT06147024
Recruiting Not applicable

Utilizing 3D Printed Personalized Aortic Lesion Models in Preoperative Assessment

NCT06147024 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Fu Jen Catholic University
Phase
Not applicable
Started
2024-04-08
Last updated
2026-02-27

Condition(s) studied

Aortic Aneurysm

Investigational drug(s) / intervention(s)

historical control3D printed lesion model

historical control: Received a conventional preoperative assessment

3D printed lesion model: Received 3D printed lesion models for preoperative planning

Study summary

Using 3D printing technology to create personalized models of diseased heart and aortic blood vessels, surgeons can perform preoperative planning and evaluate relevant indicators.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with thoracic or abdominal aortic aneurysm * Signed surgical consent * Non-emergent surgery * Had 2D CT imaging within the last 6 months Exclusion Criteria: * Refusal to use lesion images for model creation * Refusal to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fu Jen Catholic University Hospital, Fu Jen Catholic University New Taipei City Taiwan Recruiting

More Fu Jen Catholic University trials in Taiwan

Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease Recruiting
Multimodal Deep Learning Model for Predicting the Apnea-Hypopnea Index in Obstructive Sleep Recruiting
Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease Recruiting
AI-Powered Virtual Human Simulation in Students Starting soon
Use of 3D Printing High-fidelity Craniofacial Manikin to Teach Noninvasive Positive Pressure Ventilation Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06147024 on ClinicalTrials.gov ↗ ← All trials in Taiwan